Recent evidence suggests that human cells require more genetic changes for neoplastic transformation than do their murine counterparts. However, a precise enumeration of these differences has never been undertaken. We have determined that perturbation of two signaling pathways-involving p53 and Raf-suffices for the tumorigenic conversion of normal murine fibroblasts, while perturbation of six pathways-involving p53, pRb, PP2A, telomerase, Raf, and Ral-GEFs-is needed for human fibroblasts. Cell type-specific differences also exist in the requirements for tumorigenic transformation: immortalized human fibroblasts require the activation of Raf and Ral-GEFs, human embryonic kidney cells require the activation of PI3K and Ral-GEFs, and human mammary epithelial cells require the activation of Raf, PI3K, and Ral-GEFs.
Introduction
human cell types to undergo transformation to a tumorigenic state Hahn and Weinberg, 2002b) . These observations further substantiated that human cell transformaMuch of our current understanding of how cell transformation occurs in human tissues derives from studies undertaken in tion requires perturbation of several additional pathways beyond those required for murine cell transformation. rodent cells. However, emerging evidence has begun to indicate fundamental differences in the behavior of rodent and human
We subsequently demonstrated that the functions of SV40 LT oncoprotein in these experiments can be phenocopied by cells, specifically in certain biological traits relevant to the transformation process. For example, whereas prolonged culturing using a dominant-negative oligomerization mutant of p53 and an INK4a-resistant mutant of CDK4 plus overexpressed cyclin of mouse embryonic fibroblasts (MEFs) under regular culture conditions results in their spontaneous immortalization, compa-D1 (Hahn et al., 2002) . More recently, short-interfering (si)RNAmediated suppression of p53 and pRb has been shown to rerable treatment of human fibroblasts leads instead to replicative quiescence. Furthermore, introduction of combinations of oncoplace LT in similar experiments (Voorhoeve and Agami, 2003) . Taken together, these data indicate that LT contributes to expergenes such as E1AϩRas or mycϩRas readily induces transformation of primary rodent cells, while introduction of the same imental human cell transformation primarily through its actions on p53 and pRb. The precise mechanistic functions of the SV40 combination of oncogenes fails to transform primary human cells (Hahn and Weinberg, 2002a; Rangarajan and Weinberg, ST oncoprotein in this process have remained unclear. However, it has been shown very recently that the ST oncoprotein may 2003). These observations indicated that mouse and human cells indeed have quite distinct requirements for cellular transexert its oncogenic potential by preventing dephosphorylation of c-Myc, thereby resulting in c-Myc stabilization (Yeh et al., formation.
We have previously found that the introduction of three 2004).
Signaling by the Ras oncoprotein itself activates multiple genetic elements-specifically, the SV40-early region (encoding both the LT and small T antigens, which together inactivate p53, downstream signaling pathways (Campbell et al., 1998) , and differing requirements for the activation of these Ras "effector" pRb, and some activities of protein phosphatase 2A), a gene encoding the hTERT catalytic subunit of the human telomerase pathways have also been reported (Shields et al., 2000) . More specifically, the three major Ras-downstream effectors known holoenzyme (which helps to maintain the telomeric ends), and a gene specifying an oncogenic allele of Ras (which provides to have important functions in Ras-mediated transformation are Raf, PI3K, and the Ral guanine nucleotide exchange factors both mitogenic and survival signals)-causes a variety of normal S I G N I F I C A N C E Substantial differences exist in the requirements for the transformation of rodent cells compared to human cells. The 6 changes required for the experimental transformation of cultured human fibroblasts, when compared with the 2 required by mouse fibroblasts, as described here, are likely to be reflected in the complexities of multistep tumor progression in the two species. This, in turn, may affect the ability of certain rodent models of carcinogenesis to accurately mimic tumorigenesis in humans. Furthermore, the differing requirements for transformation of different human cell types-fibroblasts, embryonic kidney cells, and mammary epithelial cellssuggests that their intrinsic biological differences must be taken into account when attempting to extrapolate transformation mechanisms of one cell type to those governing others.
(Ral-GEFs) (Shields et al., 2000) . While sole activation of the months) without generating any spontaneously immortalized clones. Raf pathway has been shown to suffice for Ras-mediated transSince introduction of the gene encoding the catalytic subunit formation of NIH3T3 immortalized mouse fibroblasts (Campbell of human telomerase (hTERT) into presenescent human BJ deret al., 1998; Rodriguez-Viciana et al., 1997) , activation of this mal fibroblasts has been shown to bypass replicative senespathway alone did not transform immortalized human BJ fibrocence and cause immortalization (Vaziri and Benchimol, 1998) , blasts, MCF-10A human breast epithelial cell lines, or RIE rat we introduced a retroviral vector expressing hTERT into hFS intestinal epithelial cells (Hamad et al., 2002; Shields et al., 2000;  fibroblasts. In agreement with prior observations, introduction Oldham et al., 1996) . These data suggest that both speciesof hTERT rendered hFS fibroblasts immortalized, as they continand/or cell type-specific differences are likely to exist in the ued to proliferate beyond P70 without any signs of growth retarrequirements of Ras-pathways for transformation. dation ( Figure 1B ). In contrast, ectopic expression of mTERT While various studies indicate the existence of differences into presenescent mouse fibroblasts did not prevent their early in the mechanisms of transformation of mouse and human cells, entrance into senescence ( Figure 1B ), despite the induction of none has systematically enumerated these differences. Some greatly enhanced telomerase activity (data not shown). Thus, studies have compared cells of the two species at different the mechanisms controlling entrance into senescence of human ages, such as adult cells from one species versus embryonic and mouse cells in culture appeared to be quite different, in cells from the other. Yet other studies have been undertaken that one was prevented by ectopic telomerase expression while using different cells originating in different tissues, such as fithe other was not. broblasts of one species versus epithelial cells of the other (Drayton et al., 2003; Hamad et al., 2002; Oldham et al., 1996) .
Escape from Ras-induced senescence Moreover, different experimental methods have been employed
Although oncogenic Ras mediates transformation of immortalto introduce foreign genes.
ized MEFs, its expression in either primary MEFs or human In the present study, we have attempted to overcome many primary fibroblasts has been shown to cause a senescenceof these limitations. To do so, we have employed fibroblasts like growth arrest (Serrano et al., 1997) . The p53 and pRb tumor originating from the same tissue compartment and of comparasuppressor pathways have been shown to be intimately involved ble developmental ages in the two species. We also explored in regulating this form of senescence; they are in turn regulated the requirements for transforming human cells derived from by the Arf and Ink4a proteins, respectively, both of which are distinct cell lineages. These studies indicate substantial differencoded by the Ink4a/Arf locus (Sherr, 2001) . MEFs lacking Arf ences in the genetic elements required for cell transformation or p53 (Harvey et al., 1993; Kamijo et al., 1997) whereas adult human fibroblasts lacking functional Ink4a (Huot et al., 2002) , but not p53 (Wei et al., 2001) , avoid Ras-induced Results senescence. This suggests that the p53 pathway plays a central role in regulating Ras-induced senescence of murine cells, while Species-specific differences regulate immortalization the Rb pathway appears to play the predominant role in human In order to compare murine and human cellular requirements cells. Since escape from Ras-induced senescence is likely to for transformation in a well-controlled way, we obtained very be essential for Ras-mediated cell transformation, we sought early passage human dermal fibroblasts from newborn foreskin, to determine the respective roles of these two pathways in sidehereafter referred to as hFS fibroblasts. To obtain tissue-and by-side comparisons of mNBS and hFS fibroblasts. developmental stage-matched murine fibroblasts, we prepared
To do so, we introduced retroviral vectors encoding SV40 dermal fibroblasts from the skin of newborn (day 3) male pups LT cDNA and its mutant derivatives into these two cell types. of the C57/BL6 inbred mouse strain, which we term mNBS Wild-type LT binds to and inactivates both p53 and the family fibroblasts. Since the restricted replication potential of human, of "pocket proteins" (i.e., pRb, p107, and p130). Its mutant but not murine, primary cells in vitro has been suggested to derivative LTK1 binds and inactivates only p53, while another represent a barrier to immortalization and transformation (Newmutant form LT⌬434-444 binds and inactivates only the pocket bold et al., 1982; Sager, 1991) , we first compared the in vitro proteins (Hahn et al., 2002) . We assessed the functional efficacy long-term growth properties of these two types of cells.
of the LT K1 mutant by measuring the p53-dependent upregulaIn keeping with prior observations made with mouse embrytion of p21 protein in response to DNA damage, and that of onic fibroblasts (MEFs) (Todaro and Green, 1963) , mNBS fibro-LT⌬434-444 by measuring E2F-activity in confluent cultures, blasts grown in standard tissue culture conditions showed a and found it to be comparable in both mouse and human cells widespread senescence-like phenotype (enlarged, flattened (data not shown). morphology) and associated acidic ␤-galactosidase enzyme acSince primary human fibroblasts differ from their murine tivity by passage 6 ( Figure 1A ). After passage 8 (P8), however, counterparts in that they lack readily detectable endogenous clones of spontaneously immortalized mouse fibroblasts began telomerase expression and activity, we reasoned that we should to emerge ( Figure 1B ). In contrast, and also consistent with compare the requirements of primary hFS fibroblasts expressing previous observations (Hayflick and Moorhead, 1961) , hFS fiectopic hTERT and primary mNBS fibroblasts to escape Rasbroblasts proceeded to proliferate until passage 53 (P53), when induced senescence. they first showed signs of widespread replicative senescence
We infected early passage primary mNBS fibroblasts with (Figure 1 ). The senescent hFS fibroblasts remained in this retroviruses specifying the cDNAs of LT, LTK1, or LT⌬434-444, or alternatively with control retroviruses. Parallel cultures of early growth-arrested state for prolonged periods of time (up to six and histochemical staining for SA-␤-galactosidase activity (bottom panel) of mNBS and hFS fibroblasts at the indicated passage number. All images are at the same magnification (scale bar ϭ 100 m). B: Long-term growth curves for mouse and human fibroblasts. Graphs show passage history of mNBS and hFS fibroblasts in the absence (black ᭡) or presence (green ᭹) of ectopic TERT expression. Cultures were passaged 1:4 at ‫%08ف‬ confluency. A brief plateau (arrow) can be seen in mNBS cultures around passage 7, which indicates the senescence phase. The senescence phase in primary hFS fibroblasts is seen starting at passage 53.
passage hFS fibroblasts were serially infected with one of the et al., Sharpless et al., 2001 ). However, we observed that LT⌬434-444-carrying murine cells also escaped Ras-induced LT-encoding retroviruses followed by hTERT-encoding retrovirus, and drug-resistant clones were selected. The resultant cells growth arrest, consistent with the behavior of triple knockout MEFs (i.e., pRb et al., 2000) . Taken were subsequently infected with a retrovirus specifying oncogenic V12 H-Ras (hereafter referred to as Ras) or a control together, these observations indicate that inactivation of either p53 or the Rb family of pocket proteins enables murine fibroretrovirus, and drug-resistant colonies were then selected. The passage number of these cells following infection with Rasblasts to evade Ras-induced senescence. Consistent with prior reports (Wei and Sedivy, 1999) , Ras encoding or corresponding control retrovirus is denoted as PЈ.
Immunoblot analysis was performed at PЈ1 to confirm exinduced the senescence of hTERT-immortalized hFS fibroblasts, as assessed by change in morphology and SA-␤-galacpression of both LT and Ras proteins (Figure 2A ). Very low protein levels of the LT⌬434-444 protein were detected in both tosidase activity ( Figure 2B , right panel). It has been shown previously that inactivation of either p53 or pRb alone is not murine and human cells, consistent with prior observations indicating that mutations in this domain of the protein render the sufficient to overcome Ras-induced senescence in human fibroblasts (Serrano et al., 1997) , whereas inactivation of both of protein product metabolically unstable (Tevethia et al., 1988) . Introduction of the Ras-encoding vector resulted in a Ͼ10-fold these pathways allows escape from this growth arrest (Hahn et al., 2002) . In consonance with these results, we observed that elevated oncogenic Ras expression compared to endogenous Ras expression levels in both mouse and human cells (Fig- the hTERT-and LTK1-or LT⌬434-444-expressing fibroblasts showed senescence-like responses at PЈ2 following introducure 2A).
Like WT-MEFs (Serrano et al., 1997) , primary mNBS fibrotion of the ras oncogene, whereas LT-WT-expressing cells escaped ( Figure 2B ). However, by PЈ4, the LTK1 and LT⌬434-444 blasts succumbed to Ras-induced senescence at PЈ2 following Ras infection and drug selection. These cells scored positive cultures that contained a high proportion of senescent cells spontaneously gave rise to colonies of Ras-tolerant cells ( Phase contrast or bright-field images of histochemical staining for SA-␤-galactosidase activity in mNBS and hFS fibroblasts. Primary fibroblasts expressing the different LT forms (LTK1, LT⌬434-444, or LT-WT), hTERT (in the case of hFS fibroblasts), and oncogenic Ras (Ras) or control vector (V) were stained at PЈ2 and PЈ4. Scale bar ϭ 250 m. C: Immunoblot analysis of Ras expressed in hFS fibroblasts. hTERT-expressing cells infected with a control retrovirus (V) or a retrovirus encoding oncogenic Ras were analyzed at PЈ6, and different forms of LT antigen (LTK1 or LT⌬434-444) plus hTERT-expressing cells infected with a retrovirus encoding oncogenic Ras were analyzed at PЈ4. D: Immunoblot analysis of endogenous Ink4a expressed in hFS fibroblasts. hTERT-expressing cells infected with a control retrovirus (V) or a retrovirus encoding oncogenic Ras were analyzed at PЈ1, and LTK1 (the mutant form of LT which does not bind pRb) plus hTERT-expressing cells infected with a retrovirus encoding oncogenic Ras were analyzed at PЈ1 and PЈ4.
emergence of Ras-tolerant clones in LTK1-expressing cells (Fig- hTERT plates infected with Ras; nevertheless, Western blot analysis revealed that these cells expressed low levels of ectopic ure 2D). These results are consistent with a recent study demonstrating that siRNA-mediated suppression of p53-expression in Ras compared to cells at PЈ1 (Figures 2A and 2C ), suggesting the selection of clonal outgrowths of cells that managed to shut human BJ-hTERT fibroblasts enabled them to escape from Rasinduced senescence (Voorhoeve and Agami, 2003) .
down Ras expression deriving from the retroviral vector. Taken together, these data demonstrated that in both hFS-fibroblasts By PЈ6, clones of cells began to emerge even from hFS- (expressing hTERT) and primary mNBS fibroblasts, the presAdditional expression of mTERT did not further the transformed phenotype of these cells (data not shown). ence of either LTK1 or LT⌬434-444 enables escape from Rasinduced senescence, indicating that inactivation of either p53
In the same experiment, however, Ras failed to elicit efficient colony formation from hFS human fibroblasts expressing LTK1, or Rb-family proteins (pRb, p107, and p130) alone suffices to enable escape from Ras-induced growth arrest in these human LT⌬434-444, or LT-WT, together with, in all cases, hTERT (Figure 3A) . Very small, microscopic clumps containing 5-10 cells cells. Thus, both mouse and human neonatal dermal fibroblasts have essentially identical requirements for tolerating oncogenic were observed at a very low frequency compared to vector control cells (data not shown). These cells also failed to form Ras-expression.
tumors in mice ( Figure 3C ), indicating that inactivation of p53 or Rb family members alone or in concert is not sufficient for
Requirements of SV40 functions
Ras-mediated transformation of human fibroblasts, even in the for Ras-mediated transformation presence of ectopically expressed hTERT. We next determined the transformation-related phenotypes of
We have previously demonstrated that hTERT-immortalized these Ras-expressing cells. Oncogenic Ras enabled mNBS fihuman BJ fibroblasts require the additional actions of the small broblasts expressing LTK1, LT⌬434-444, or WT LT to form large T (ST) oncoprotein, along with loss of pRb and p53 functions, and robust colonies in soft agar with comparable efficiencies to undergo Ras-mediated transformation (Hahn et al., 2002) . (Figure 3A) , while the empty vector-containing cells failed to
To test whether hFS fibroblasts also required ST functions for generate any colonies. Furthermore, when injected into mice transformation, we serially introduced the SV40-early region subcutaneously, all cell types that generated anchorage-inde-(which encodes both LT and ST; henceforth SV40-ER), hTERT, pendent colonies also formed tumors in vivo with comparable and oncogenic ras into primary hFS fibroblasts. We additionally growth kinetics ( Figure 3B ). Thus, consistent with prior observations demonstrating that MEFs derived from p53-or pRb/p107/ introduced a retroviral vector encoding the cDNA version of ST in trans in cells already expressing LTK1, LT⌬434-444, or LT p130 null mice (Sage et al., 2000) can be transformed by oncogenic Ras, our results demonstrated that inactivation of either together with hTERT. The resultant drug-resistant cells were subjected to transformation assays. p53 or the family of pRb-related pocket proteins is sufficient for Ras-mediated tumorigenesis of primary mouse fibroblasts.
As anticipated, hFS fibroblasts expressing SV40-ERϩ hTERTϩRas formed robust colonies in soft agar ( Figure 3A ) and ( Figure 4A ). Specific activation of downstream pathways by different Ras effector mutants was verified as described in Figalso generated tumors when injected subcutaneously into nude ure 5 (data not shown). mice ( Figure 3C ). We observed that the SV40-ER-encoding retWe proceeded to determine which of these cell populations rovirus resulted in higher expression of the LT oncoprotein were capable of anchorage-independent growth. In contrast to compared to the LT cDNA-encoding retrovirus (Figure 2A) . Also, control vector cells, mNBS fibroblasts expressing the S35 Ras ST-expressing human fibroblasts expressed higher levels of Ras mutant and LT formed colonies with maximum efficiency, oncoprotein compared to non-ST expressing fibroblasts (Figure whereas cells expressing G37 or C40 plus LT generated only 2A). Nonetheless, introduction of ST in trans in hFS fibroblasts a few, very small colonies ( Figure 4B ). When injected subcutanealready expressing LT-WTϩhTERTϩRas resulted in efficient ously into nude mice, the S35-expressing cells generated tucolony formation ( Figure 3A ) and tumor growth (in all 6 out of mors in 8 out of 9 injections, albeit with a slightly increased 6 injections), thus confirming the essential role of ST in this latency compared to cells expressing oncogenic Ras bearing transformation.
a wild-type effector domain ( Figure 4C ). The G37-expressing In the same experiment, introduction of ST in both LTK1 cells failed to initiate any tumors, while only 1 out of 9 injections and LT⌬434-444 plus hTERT-expressing hFS cells resulted in of the C40-expressing cells generated a small tumor. These the generation of small and abortive colonies in contrast to the observations indicate that activation of the Raf pathway alone large and robust colonies formed by SV40-ERϩhTERTϩRas suffices for both anchorage-independent growth and in vivo expressing cells ( Figure 3A) . These ST-expressing cells also tumorigenicity of LT-immortalized mouse primary fibroblasts, failed to form tumors in mice (in all 6 out of 6 injections), demonconsistent with prior studies performed in spontaneously imstrating that even though inactivation of either p53 or pRb-family mortalized NIH3T3 MEFs (Campbell et al., 1998 ; Rodriguezis sufficient to escape from Ras-induced growth arrest, neither Viciana et al., 1997) . of these changes, on its own, suffices for transformation to a
In contrast, none of the Ras effector loop mutants, when tumorigenic state.
expressed on its own, induced robust colony formation by Together, these experiments demonstrated clearly that SV40-ERϩhTERT-expressing human fibroblasts, although a low human fibroblasts require the inactivation of both p53 and pRbnumber of small colonies was observed in cells expressing C40 family plus expression of hTERT, ST, and Ras, whereas inactivawhen compared to vector control cells ( Figure 4B ). These results tion of either p53 or pRb-family members suffices for Rascontrast with those described in a recent report demonstrating mediated transformation of murine fibroblasts. Accordingly, five the ability of SV40-ERϩhTERT-immortalized human BJ fibroalterations were required to transform human fibroblasts, while blasts expressing only the G37 mutant to efficiently form anchortwo were required for their murine counterparts.
age-independent colonies (Hamad et al., 2002) . The reasons for this discrepancy are unknown. On the basis of our experiImmortalized human fibroblasts require activation ments, we conclude that activation of any one of the three major of Raf and Ral-GEFs for tumorigenic transformation Ras effector pathways, on its own, is insufficient to mediate While acquisition of a mutant ras allele or introduction of a efficient anchorage-independent colony formation by SV40-ras oncogene represents a single genetic alteration, the Ras ERϩhTERT-expressing hFS fibroblasts. oncoprotein that results actually controls a number of distinct We next determined whether concurrent activation of any downstream signaling pathways (Campbell et al., 1998 ; Shields two Ras-downstream pathways might cooperate in the transforet al., 2000). We therefore sought to dissect the respective mation of human fibroblasts. To do so, we generated SV40-contributions of these effector pathways to Ras-mediated transERϩhTERT-expressing hFS fibroblasts carrying pairs of Ras formation of mouse and human cells. The three Ras effector mutants (S35ϩG37, S35ϩC40, or G37ϩC40) by introducing a pathways known to play major roles in cellular transformation second Ras effector mutant expressed by a retroviral vector have been shown to involve the Raf, PI3K, and Ral-GEF proteins encoding a different drug resistance marker. The expression (Shields et al., 2000) . In order to explore which of these pathways levels of Ras and Ras mutants generated by this vector were is required for transformation of mouse and human fibroblasts, tested and found to be similar to those expressed in the previous we employed effector-loop mutants of oncogenic Ras (Rodriexperiments from a different retroviral vector (data not shown). guez-Viciana et al., 1997). These mutants are single aminoWe observed that the pairwise expression of S35ϩG37 and acid substitutions in the effector loop domain of oncogenic V12 S35ϩC40 into human fibroblasts enabled efficient colony for-H-Ras that cause each of them to preferentially activate only mation, although not as robust as those induced by oncogenic one of the three above-mentioned effector pathways. Thus, the Ras bearing the wild-type effector domain ( Figure 4B ). In con-V12H-Ras T35S mutant binds and activates Raf, but not PI3K or trast, the combination of G37ϩC40 failed to generate robust Ral-GEF, the V12H-Ras E37G mutant binds and activates only Ralcolonies. When injected into nude mice, however, only those GEFs, and the V12H-Ras Y40C mutant binds and activates only cells expressing the combination of S35ϩG37 formed tumors PI3K (Rodriguez-Viciana et al., 1997). These mutants of oncoin vivo, albeit with an increased latency when compared with the genic Ras are hereafter referred to as S35, G37, and C40 respectumors induced by oncogenic Ras bearing a wild-type effector tively. domain ( Figure 4E ). Cells expressing G37ϩC40 formed 1 tumor The cDNAs specifying these various Ras mutants were introout of 9 injections with a further increased latency. Taken together, duced into LT-expressing cultures of mNBS fibroblasts and these results demonstrate that SV40-ERϩhTERT-immortalized SV40-ERϩhTERT-expressing hFS fibroblasts. Polyclonal popuhuman fibroblasts specifically require the activation of Raf and lations of cells expressing the various Ras mutants were found Ral-GEF pathways for tumorigenicity, while activation of Raf alone to express levels of H-Ras oncoprotein comparable to those was sufficient for transforming LT-immortalized murine fibroblasts. expressing oncogenic Ras with a wild-type effector domain 
. Requirements of Ras pathways for transforming mNBS and hFS fibroblasts
A: Immunoblot analysis of Ras protein expression in mNBS fibroblasts overexpressing LTcDNA or SV40-ER (which encodes both LT and ST) and hFS fibroblasts overexpressing SV40-ERϩhTERT. These cells were subsequently infected with control retroviruses (V), retroviruses encoding oncogenic Ras (Ras), or individual Ras effector loop mutants (S35, G37, or C40, which preferentially activate Raf, Ral-GEFs, or PI3K, respectively). B: Soft agar colony formation of mNBS (top panel) and hFS fibroblasts (bottom panel). Murine fibroblasts overexpressing LT-WT or SV40-ER, and oncogenic Ras, Ras effector loop mutants, or vector control were analyzed. Similarly, hFS fibroblasts overexpressing SV40-ER, hTERT and oncogenic Ras, control vector, or Ras effector loop mutants (individually or in pairs) were analyzed. Figure shows representative photomicrographs of colonies generated by mNBS cells seeded at 1 ϫ 10 4 cells/plate and hFS cells seeded at 5 ϫ 10 4 cells/plate.
C-E: Tumor growth curves formed by mNBS and hFS fibroblasts. Graphs represent growth curves of tumors formed by mNBS fibroblasts overexpressing LT-WT and oncogenic Ras (᭛), S35 (᭺), G37, C40, or control vectors (represented by ᭹) (C). Growth curves of tumors formed by mNBS fibroblasts overexpressing SV40-ER and oncogenic Ras (᭛), S35 (O), G37 (⌬), C40 (c), or control vector (᭹) (D). Growth curves of tumors formed by hFS fibroblasts overexpressing SV40-ERϩhTERT and oncogenic Ras (᭛), S35ϩG37 (⌬), G37ϩC40, S35ϩC40, S35, G37, C40, or control vector (represented by ᭹) (E).
Since the human fibroblasts used in these experiments addially into these cells. We observed that the SV40-ER-expressing murine fibroblasts formed colonies in soft agar at a low fretionally carried the ST oncogene compared with mouse fibroblasts, this raised the possibility that interaction of ST with the quency even without Ras ( Figures 3A and 4B ). Subsequent introduction of any of the Ras mutants sufficed to cause robust Ras pathways might somehow play a role in this observed discrepancy. In order to address this issue, we generated murine and efficient transformation of these cells, comparable to that seen with cells expressing oncogenic Ras bearing a wild-type fibroblasts expressing the SV40-ER (which encodes both LT and ST) and then introduced each of the Ras mutants individueffector domain ( Figure 4B ). Additionally, in contrast to cells Figures 4B and 4D ). This may, in part, be explained by cooperation between the slightly elevated only S35 expression for transformation ( Figures 4B and 4C) , whereas ERϩhTERT-immortalized hFS cells failed to be trans-MAPK activity detected in the ER-expressing mNBS cells (com- formed by expression of any single Ras effector loop mutant. Similar to the observed responses of human fibroblasts, activation of any one Ras effector pathway failed to mediate While coexpression of S35 and G37 or C40 into ERϩhTERT containing hFS cells gave rise to colony formation in vitro, only anchorage-independent growth of HA1E cells in vitro ( Figure  5B ). These results again contrast with those described in a the combination of S35 and G37 formed tumors in nude mice ( Figures 4B and 4E ). One possible reason why S35 expression recent report demonstrating the ability of SV40-ERϩhTERT-immortalized HEK cells expressing only the G37 mutant to effialone sufficed for mNBS transformation could be that the basal activity of the Ral-GEF and PI3K activity is higher in mNBS ciently form anchorage-independent colonies (Hamad et al., 2002) . The reasons for this discrepancy are unknown and may fibroblasts. If this were so, then LT-expressing mNBS fibroblasts should, on their own, show colony formation in soft agar, since derive from the use of cells that had been propagated in culture extensively before their genetic manipulation. cooperation between Ral-GEF and PI3K pathway has previously been shown to transform murine fibroblasts (Rodriguez-Viciana
We then introduced a second Ras mutant into these cells, and resultant cells were subjected to soft agar analysis. We et al., 1997). However, we failed to detect any soft agar colony formation in LT-expressing mNBS cells ( Figure 3A) . Furtherobserved that only the specific combination of G37 and C40 mediated robust and efficient anchorage-independent growth, more, we failed to detect any difference in the basal activity of the Ral-GEF and PI3K pathway between mNBS and hFS cells comparable to those formed by oncogenic Ras bearing a wildtype effector binding domain ( Figure 5G ). This demonstrated (data not shown).
Taken together, these and the earlier experiments demonthat immortalized HEK cells require specific activation of RalGEFs and PI3K, but not Raf, for transformation in vitro as gauged strated that while perturbation of two signaling pathways involving p53 and Raf sufficed for the tumorigenic transformation of by anchorage-independent growth. Thus, whereas activation of the Raf ϩ Ral-GEF or the Raf ϩ PI3K effectors was required newborn murine fibroblasts, transformation of human foreskin fibroblasts required the perturbation of these two pathways plus for the anchorage-independent growth of human fibroblasts, at least four additional pathways, involving Rb, hTERT, PP2A, specific activation of PI3K and Ral-GEFs was required for the and Ral-GEFs (Table 1) . same outcome in human embryonic kidney cells. In order to rule out the contribution of direct or indirect activation of additional Ras-pathways by the various Ras efActivation of PI3K and Ral-GEFs is both necessary and sufficient for tumorigenic transformation fector-loop mutants, we measured the biochemical responses evoked by each of these mutants. We monitored the levels of of immortalized human embryonic kidney cells The cell physiologic actions of the various Ras effector pathways phospho-ERK1/2 and Akt, which act as good indicators of the activation of Raf and PI3K pathway, respectively. In order to have usually been defined in the context of fibroblasts. However, emerging evidence suggests that there may be cell type-specific measure the activation of Ral-GEFs, we measured the activation of their downstream component Ral by performing GTP-Ral differences in the requirements of Ras effectors for cellular transformation (Hamad et al., 2002; Shields et al., 2000) . We pulldown assays. These data confirmed that distinct Ras mutants indeed activated specific downstream effector pathways therefore assessed the requirement of the Ras effector pathways in the transformation of human embryonic kidney cells ( Figures 5C-5E ).
To further confirm that activation of PI3K plus Ral-GEFs is (HEKs), which originate from the embryonic mesoderm and possess both mesenchymal and epithelial characteristics. sufficient for transforming HA1E cells, we introduced constitutively active components of these two pathways into immortalWe previously found that HEK cells can be immortalized by the introduction of the SV40-ER and a construct encoding ized HA1E cells. Thus, concomitant expression of a constitutively active mutant of Akt and Rlf (a Ral-GEF family member; hTERT, and that such immortalized cells can then be transformed by expression of a Ras oncoprotein .
Rlf-CAAX) enabled anchorage-independent colony formation in HA1E cells, whereas individually they failed to do so (Figure Thus, these immortalized HEK cells, termed HA1Es , offer a good system to dissect the requirements of 5F). Furthermore, inhibition of PI3K using a chemical inhibitor, LY294002, or inhibition of the Ral-pathway via a dominantRas signaling for transformation. We introduced the three Ras mutants into these cells individually, confirmed high levels of negative mutant of Ral inhibited colony formation in Ras-transformed HA1E cells ( Figure 5G ). Taken together, these results expression of each Ras mutant by Western blotting ( Figure 5A ), and thereafter assessed their transformation behavior.
confirmed that the activation of the P13K and Ral-GEF pathways is both sufficient and necessary for in vitro transformation of pathways by the various Ras effector loop mutants (data not immortalized HA1E cells.
shown), we sought to determine the transformation potential of We next determined whether expression of G37 and C40 these various HMLE cells. also sufficed for tumor formation. To this end, we introduced While introduction of S35 and C40 alone, but not G37, gener-HA1E cells expressing the Ras mutants, either singly or in pairs, ated soft agar colonies when compared to vector control cells, into nude mice. Only the combination of G37 and C40 yielded their numbers were low when compared to those induced by tumors in nude mice, although with an increased latency comoncogenic Ras bearing a wild-type effector domain ( Figure 6B ). pared to that of cells expressing oncogenic Ras bearing a wildWhen a second, distinct Ras effector mutant was introduced type effector loop domain ( Figure 5H ).
into these cells, all the pairwise combinations formed colonies. Taken together, these experiments demonstrate that conHowever, the colonies were still fewer in number than those current activation of PI3K and Ral-GEFs is both sufficient and induced by oncogenic wild-type Ras acting on its own ( Figure  necessary for the Ras-mediated tumorigenic transformation of 6B). To be more precise, the combination of S35 and C40 formed immortalized human embryonic kidney cells, in contrast to the colonies more efficiently than did the other two pairwise combirequirement of Raf and Ral-GEFs needed for the tumorigenic nations. When these various cells were introduced into nude conversion of human fibroblasts (Table 1) . mice, none of the cells expressing the effector mutants either singly or in pair-wise combinations generated tumors in vivo Tumorigenic transformation of immortalized human ( Figure 6C ).
mammary epithelial cells requires activation
In order to exclude the possibility that reduced levels of of Raf, PI3K, and Ral-GEFs mutant Ras proteins were responsible for the failure to transform Since Ras mutations are commonly associated with epithelial these immortalized HMECs to tumorigenic derivatives, we introtumors (Bos, 1989) , we further assessed the requirements of duced the S35 mutant of Ras into HMLE cells that were already Ras-effector pathways in the transformation of one frequently expressing both the G37 and C40 effector loop mutants of studied type of human epithelial cell-human mammary epitheoncogenic Ras. The resultant HMLE cells concomitantly exlial cells (HMECs) . We have previously demonstrated that intropressing all three Ras effector-loop mutants efficiently formed duction of SV40-ER and hTERT into HMECs immortalizes them robust colonies that were larger than those created by the Ras (Elenbaas et al., 2001) . Subsequent expression of supraphysiooncoprotein carrying a wild-type effector domain ( Figure 6B ). logical levels of oncogenic Ras caused these cells to undergo This demonstrated that the individual Ras mutants, when extumorigenic conversion (Elenbaas et al., 2001) . Accordingly, pressed singly or in pairs, were indeed being expressed at levels these immortalized HMECs, hereafter referred to as HMLEs, that were compatible with efficient transformation. Thus, these represented a useful reagent to assess the requirements for Ras results indicated that activation of all three major components effector signaling in epithelial cell transformation. We therefore of Ras signaling pathways was essential for the tumorigenic introduced retroviral vectors specifying the three Ras mutants transformation of human mammary epithelial cells, further deminto HMLE cells. Western blot analysis revealed that the levels onstrating that different human cell types indeed have distinct of Ras effector loop mutants being expressed were comparable requirements of Ras effector pathways for transformation to that of oncogenic Ras bearing a wild-type effector domain ( Figure 6A ). After confirming specific activation of downstream (Table 1) .
Discussion
gether with the present results demonstrating differential requirements of Ras-effector pathways for transformation of cells from distinct tissue types (Table 1) , may explain why certain RasThe extensive use of mouse models of human cancer pathogenesis has yielded a wealth of insights into the mechanistic details oncoproteins are frequently associated with tumors of certain tissues (Downward, 2003) . of tumor progression in humans. Nonetheless, the great evolutionary distance separating humans and mice has led to subIn addition to differences in the requirements of Ras pathways for transformation of different cell types, other cell typestantial differences in the biology of these two mammalian species (Rangarajan and Weinberg, 2003) . Some of these divergent specific variations have also been observed. For example, while expression of the catalytic domain of human telomerase alone biological features might well reside at the level of individual cells and at the subcellular circuits governing various aspects suffices to immortalize human fibroblasts and endothelial cells, human mammary epithelial cells and keratinocytes additionally of cell behavior, including the processes of oncogenic transformation.
require inactivation of the p16/Rb pathway (Hahn and Weinberg, 2002a) . At present, it is unclear whether these differences in The present observations demonstrate that profound differences do indeed exist in the mechanisms of experimental transrequirements for immortalization reflect fundamental differences in cell biology (that may also affect transformation), or simply formation of cultured human and murine fibroblasts. Nonetheless, these findings have intrinsic limitations. Our comparisons differing requirements for survival in tissue culture. Multiple chemotherapeutic drugs targeting the Ras pathare influenced by the particular identities of the cell types being studied, and we could well imagine that other pairs of humanways have been generated that fare well in preclinical trials performed in mouse xenograft models; however, the clinical mouse cell populations prepared from tissues not examined in the present work might exhibit greater or lesser differences than responses observed in early stage human trials have not been encouraging (Downward, 2003) . If the signaling pathways cruthe pairs of cells analyzed here. Moreover, these differences might well not apply to the cells of all inbred strains of mice cial for tumor initiation and maintenance are different for cells of different species, and even for diverse cell types within the and to those of wild mice. In spite of these caveats, we conclude that interspecies differences in the biology of cell transformation same species, then it is only natural that drugs targeting specific pathways will be more effective for certain tumors than for othare substantial, and that they may compromise or confound attempts at relating the behaviors of mouse and human cells ers. This underscores the great need to precisely elucidate the requirements of various human cell types for tumorigenic transduring tumor progression.
The potential relevance of these in vitro findings to in vivo formation as a prerequisite to developing truly effective anticancer therapies. The present work, which has attempted to systumorigenesis in humans is indicated by the observations that most of the alterations described here as being essential for tematically analyze the signaling requirements of cells from different human cell types (fibroblasts, embryonic kidney cells, transforming human cells in vitro are similar or identical to those encountered in commonly occurring human tumors. For examand mammary epithelial cells), indicates that the intrinsic biological differences between various cell types must be taken into ple, ‫%09ف‬ of human tumors have acquired telomerase activity, and the remainder appear to employ alternate telomere lengthaccount when attempting to extrapolate responses of one cell type to those of another. ening mechanisms (ALT) (Shay, 1997) , indicating that telomere maintenance is a crucial event in tumor progression and that
Experimental procedures
human cancer cells must acquire this function. In addition, the SV40 LT antigen binds and inactivates two major cellular tumor Vectors suppressor proteins pRb and p53; alterations of the two regulaIndividual Ras effector loop mutants from pSG5 vector (Rodriguez-Viciana tory circuits controlled by these two proteins are observed in et al., 1997) were subcloned into pBABEpuro, pWZL blast, and pBABEmost and perhaps all types of human adult malignancies (HanaZeo retroviral vectors. The Bgl2-EcoR1 fragment of Rlf-CAAX (described in Wolthuis et al., 1997) and EcoR1 fragment of Ral-N28 (described in Urano han and Weinberg, 2000; Sherr and McCormick, 2002). et al., 1996) were subcloned into pWZL-Blast. Other constructs have been The SV40 ST oncoprotein binds and inhibits some isoforms formation of HEK cells (Chen et al., 2004) , thereby suggesting cells with a retroviral vector and amphotropic packaging plasmid pCL-10A1 that ST-mediated inactivation of this specific subunit is critical (Imgenex), or packaging plasmids encoding pCMV-VSV-G and pUMVC3-gag-pol (Aldevron) separately using Fugene 6 (Roche Molecular Biochemifor human cell transformation. Whether suppression of this comcals). Both mouse and human cells at 25% confluency were infected for ponent of PP2A action also occurs frequently in spontaneously 4 hr with viral supernatants containing 8 g/ml polybrene. Typically Ͼ80% arising human cancers remains to be demonstrated. infection efficiency was achieved using this protocol, as assessed by parallel Three members of the Ras gene family-H-Ras, K-Ras, and infections of GFP-encoding virus. After infection, fresh media was supple-N-Ras-are found to be activated by mutation in ‫%03ف‬ of all mented, and two days following infection, drug selection was initiated. Neohuman tumors (Shields et al., 2000) . Even though these various mycin, blasticidin, hygromycin, puromycin, and zeocin were used at 400, 4, 0.3, 1, and 200 g/ml for mNBS fibroblasts, and at 1500, 6, 0.3, 1, and 500 Ras proteins bind to all the three major Ras-effectors involved g/ml for hFS fibroblasts.
in transformation, differences in the efficacy with which different Ras family proteins activate specific downstream effectors have Cells and culture condition been demonstrated (Yan et al., 1998) . For example, K-Ras has Primary mouse fibroblasts were obtained from newborn pups of C57/BL6 been shown to bind and activate Raf much more efficiently than inbred mouse strain by overnight trypsinization of the skin followed by colla-H-Ras, while H-Ras has been shown to activate PI3K more genase treatment, and grown in standard tissue culture conditions of 5% CO 2 and 20% O 2 and passaged at 1:4 when ‫%08ف‬ confluent. Primary human efficiently than K-Ras (Yan et al., 1998). These data, taken to-
